OBIMF

ONDINE BIOMEDICAL RSTRCTD by Ondine Biomedical, Inc. (OBIMF)

About ONDINE BIOMEDICAL RSTRCTD by Ondine Biomedical, Inc. (OBIMF)

Ondine Biomedical, Inc. operates as a life sciences company that develops photodisinfection-based therapies to address drug-resistant infections. Its platform technology called antimicrobial photodynamic disinfection to help prevent and help treat infections across many therapeutic areas in healthcare and industry settings. The firm's novel, patented platform technology both reduces inflammation and eliminates harmful pathogens, rapidly destroying bacteria, fungi and viruses including superbugs and SARS-CoV-2. The company was founded by Carolyn Cross on September 9, 1996 and is headquartered in Vancouver, Canada.

Details

Daily high
--
Daily low
--
Price at open
--
52 Week High
$0.25
52 Week Low
$0.11
Market cap
60.3M
Dividend yield
0.00%
Volume
--
Avg. volume
48
P/E ratio
-2.85

ONDINE BIOMEDICAL RSTRCTD by Ondine Biomedical, Inc. News

Details

Daily high
--
Daily low
--
Price at open
--
52 Week High
$0.25
52 Week Low
$0.11
Market cap
60.3M
Dividend yield
0.00%
Volume
--
Avg. volume
48
P/E ratio
-2.85